Mare Evidence Lab

Kering: Tough Spot, Neutral Rating Now Source link Mare Evidence Lab

Legal & General: Strongest Subsector Yield And Solvency Ratio Source link Mare Evidence Lab

STMicroelectronics: Headwind In 2025 And Lower Long-Term Targets Source link Mare Evidence Lab

Royalty Pharma: Massive Opportunity Ahead Source link Mare Evidence Lab

Diageo: Ongoing Challenges, But It Is Still Cheap Source link Mare Evidence Lab

ElsvanderGun/iStock Unreleased via Getty Images Following our update on UniCredit-Commerzbank, today we are back to comment on Deutsche Bank Aktiengesellschaft (NYSE:DB). Since our buy rating, the company has continued its restructuring progress, and combined with a favorable interest rate environment,

boggy22 In our last UniCredit (OTCPK:UNCFF, OTCPK:UNCRY) analysis, here at the Lab, we emphasized a clear upside in the M&A. Combined with an attractive capital return and a solid balance sheet, the leading Italian bank was a clear buy opportunity.